Literature DB >> 16488475

Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease.

Alireza Rafiei1, Sussan K Ardestani, Amina Kariminia, Abdolhosein Keyhani, Mino Mohraz, Aref Amirkhani.   

Abstract

Human brucellosis is a worldwide zoonotic infectious disease which is caused by intracellular bacteria belonging to the genus Brucella. Based on murine studies it has been shown that host resistance to Brucella depends on Th1 response, whereas Th2 response is involved in the severity of the disease. Since the immune response during human brucellosis has not been profoundly studied we have tried to evaluate cytokine production in patients suffering from brucellosis. Diluted whole blood samples were cultured in the presence of the mitogen, heat inactivated bacteria or medium alone. IL-12, IFN-gamma and IL-10 were measured by specific sandwich ELISA. In addition, the percentage of CD3(+) T cells producing either IL-13 or IFN-gamma was determined by flow cytometry. It was found that not only IFN-gamma production but also the number of CD3(+) IFN-gamma-producing cells decreased with prolongation of the disease but the percentage of CD3(+) IL-13(+) T cells were significantly increased. No correlation between duration of disease and IL-10 or IL-12 production was found. In conclusion, it is proposed that at the onset of brucellosis, Th1 response dominates while diminishing with prolongation of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16488475     DOI: 10.1016/j.jinf.2005.11.024

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  32 in total

1.  Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.

Authors:  Job Alves de Souza Filho; Vicente de Paulo Martins; Priscila Carneiro Campos; Juliana Alves-Silva; Nathalia V Santos; Fernanda Souza de Oliveira; Gustavo B Menezes; Vasco Azevedo; Silvio Lorenzo Cravero; Sergio Costa Oliveira
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

2.  IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.

Authors:  Carolyn A Lacey; Catherine A Chambers; William J Mitchell; Jerod A Skyberg
Journal:  J Leukoc Biol       Date:  2019-02-12       Impact factor: 4.962

3.  Brucella alters the immune response in a prpA-dependent manner.

Authors:  Juan M Spera; Diego J Comerci; Juan E Ugalde
Journal:  Microb Pathog       Date:  2014-02-04       Impact factor: 3.738

4.  Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Authors:  Beata Clapp; Jerod A Skyberg; Xinghong Yang; Theresa Thornburg; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Evaluation of Regulatory T Cells in Patients with Acute and Chronic Brucellosis.

Authors:  Ali Ganji; Ghasem Mosayebi; Ehsanollah Ghaznavi-Rad; Khadije Khosravi; Nader Zarinfar
Journal:  Rep Biochem Mol Biol       Date:  2017-04

6.  PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages.

Authors:  Mariana N Xavier; Maria G Winter; Alanna M Spees; Andreas B den Hartigh; Kim Nguyen; Christelle M Roux; Teane M A Silva; Vidya L Atluri; Tobias Kerrinnes; A Marijke Keestra; Denise M Monack; Paul A Luciw; Richard A Eigenheer; Andreas J Bäumler; Renato L Santos; Renée M Tsolis
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

7.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

8.  Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.

Authors:  Carolyn A Lacey; Lauren L Keleher; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

10.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.